Vitamin D + magnesium

Vitamin D + magnesium has been studied in 4 papers since 2020: 3 trials in people. The newest paper, Dec 22, 2022: “Combined vitamin D and magnesium supplementation does not influence markers of bone turnover or glycemic control: A randomized controlled clinical trial”.

Intervention

4 papers study it10 findingsUpdated

See all 4 papers on vitamin D + magnesium

At a glance

The findings reach people, from one lab or study. 2 independent labs in 2 countries.

“Vitamin D plus magnesium supplementation in obese women with mild to moderate depressive symptoms has beneficial influences on mood, serum levels of BDNF, inflammation, and SIRT1.”
Randomized study of the effects of vitamin D and/or magnesium supplementation on mood, serum levels of BDNF, inflammation, and SIRT1 in obese women with mild to moderate depressive symptomsNutritional neuroscience2021doi:10.1080/1028415x.2021.1945859

None of its findings points the other way.

Humans: a single group. Cells, worms or flies and mice: nothing yet.
  • 2 independent labs in 2 countries
  • Funders: American Heart Association and 2 more
  • Human trial3

Studies in people

3 studies gave vitamin D + magnesium to people and measured what changed.

What changedDesignPeopleSource

up: Increases 25-hydroxyvitamin Ddifference = 5.63; CI, -10.0 to -1.21; P = .001

no change: Has no effect on insulin resistanceP > .05 for all

no change: Has no effect on osteocalcinP > .05 for all

Randomized trial12 weeks78 peopleBothPatient cohortsNutrition research (New York, N.Y.), Dec 22, 2022

up: Increases 25-hydroxyvitamin D6.3 ± 8.36 ng/mL

down: Decreases systolic blood pressure7.5 ± 8.26 mmHg

no change: Has no effect on parathyroid hormone

Randomized trial12 weeks95 peopleNutrition (Burbank, Los Angeles County, Calif.), Apr 1, 2022

no change: Has no effect on C-reactive protein

no change: Has no effect on depressive symptoms

Randomized trial8 weeks108 peopleWomenIn obese women with mild to moderate depressive symptomsNutritional neuroscience, Jul 2, 2021

What did studies of vitamin D + magnesium find?

9

Studies of vitamin D + magnesium measured 9 outcomes, among them 25-hydroxyvitamin D, osteocalcin and insulin resistance.

25-hydroxyvitamin D

upin humans2

2 studies
  1. Vitamin D + magnesium increases 25-hydroxyvitamin D in humans (difference = 5.63; CI, -10.0 to -1.21; P = .001).

    “significant increase in serum 25-hydroxyvitamin D concentrations in the vitamin D and magnesium group compared with the placebo group (difference = 5.63; CI, -10.0 to -1.21; P = .001)”

    Human trial12 weeks

    Combined vitamin D and magnesium supplementation does not influence markers of bone turnover or glycemic control: A randomized controlled clinical trial

    Nutrition research (New York, N.Y.)

  2. Vitamin D + magnesium increases 25-hydroxyvitamin D in humans (compared with vitamin D only) (6.3 ± 8.36 ng/mL).

    “The MagD group experienced the greatest increase in serum 25OHD concentrations (6.3 ± 8.36 ng/mL; P < 0.05).”

    Human trialcompared with vitamin D only360 mg magnesium glycinate + 1000 IU vitamin D3 three times daily12 weeksn = 95

    The effect of combined magnesium and vitamin D supplementation on vitamin D status, systemic inflammation, and blood pressure: A randomized double-blinded controlled trial

    Nutrition (Burbank, Los Angeles County, Calif.)

More on 25-hydroxyvitamin D

Osteocalcin

no changein humans1

1 study
  1. Vitamin D + magnesium showed no clear effect on osteocalcin in humans (P > .05 for all).

    “there were no differences in serum concentrations of total osteocalcin, glucose, insulin, and adiponectin or the homeostatic model assessment of insulin resistance (HOMA-IR) among groups (P > .05 for all)”

    Human trial12 weeks

    Combined vitamin D and magnesium supplementation does not influence markers of bone turnover or glycemic control: A randomized controlled clinical trial

    Nutrition research (New York, N.Y.)

More on Osteocalcin

Insulin resistance

no changein humans1

1 study
  1. Vitamin D + magnesium showed no clear effect on insulin resistance in humans (P > .05 for all).

    “there were no differences in serum concentrations of total osteocalcin, glucose, insulin, and adiponectin or the homeostatic model assessment of insulin resistance (HOMA-IR) among groups (P > .05 for all)”

    Human trial12 weeks

    Combined vitamin D and magnesium supplementation does not influence markers of bone turnover or glycemic control: A randomized controlled clinical trial

    Nutrition research (New York, N.Y.)

Systemic inflammatory markers

no changein humans1

1 study
  1. Vitamin D + magnesium showed no clear effect on systemic inflammatory markers in humans across treatment arms.

    “There were no statistically significant treatment effects on serum PTH concentrations and markers of inflammation.”

    Human trialacross treatment arms12 weeksn = 95

    The effect of combined magnesium and vitamin D supplementation on vitamin D status, systemic inflammation, and blood pressure: A randomized double-blinded controlled trial

    Nutrition (Burbank, Los Angeles County, Calif.)

More on Systemic inflammatory markers

Parathyroid hormone

no changein humans1

1 study
  1. Vitamin D + magnesium showed no clear effect on parathyroid hormone in humans across treatment arms.

    “There were no statistically significant treatment effects on serum PTH concentrations and markers of inflammation.”

    Human trialacross treatment arms12 weeksn = 95

    The effect of combined magnesium and vitamin D supplementation on vitamin D status, systemic inflammation, and blood pressure: A randomized double-blinded controlled trial

    Nutrition (Burbank, Los Angeles County, Calif.)

More on Parathyroid hormone

Systolic blood pressure

downin humans1

1 study
  1. Vitamin D + magnesium decreases systolic blood pressure in participants with baseline systolic blood pressure above 132 mmHg, MagD arm (7.5 ± 8.26 mmHg).

    “There was a decrease in systolic blood pressure (7.5 ± 8.26 mmHg; P < 0.05) for individuals who had a baseline systolic blood pressure of >132 mmHg”

    Human trialin participants with baseline systolic blood pressure above 132 mmHg, MagD arm12 weeksn = 95

    The effect of combined magnesium and vitamin D supplementation on vitamin D status, systemic inflammation, and blood pressure: A randomized double-blinded controlled trial

    Nutrition (Burbank, Los Angeles County, Calif.)

More on Systolic blood pressure

Depressive symptoms

no changein humans1

1 study
  1. Vitamin D + magnesium showed no clear effect on depressive symptoms in obese women with mild to moderate depressive symptoms.

    “No significant differences in BDI-II score were shown among the 4 groups at the end of the intervention.”

    Human trialin obese women with mild to moderate depressive symptoms50000 IU vitamin D weekly + 250 mg magnesium daily8 weeksfemalesn = 108

    Randomized study of the effects of vitamin D and/or magnesium supplementation on mood, serum levels of BDNF, inflammation, and SIRT1 in obese women with mild to moderate depressive symptoms

    Nutritional neuroscience

C-reactive protein

no changein humans1

1 study
  1. Vitamin D + magnesium showed no clear effect on C-reactive protein in humans.

    “But, we found no significant differences in terms of hs-CRP and SIRT1 levels.”

    Human trial50000 IU vitamin D weekly + 250 mg magnesium daily8 weeksfemalesn = 108

    Randomized study of the effects of vitamin D and/or magnesium supplementation on mood, serum levels of BDNF, inflammation, and SIRT1 in obese women with mild to moderate depressive symptoms

    Nutritional neuroscience

More on C-reactive protein

Inflammation

downin humans1

1 study
  1. Vitamin D + magnesium decreases inflammation in humans.

    “Vitamin D plus magnesium supplementation in obese women with mild to moderate depressive symptoms has beneficial influences on mood, serum levels of BDNF, inflammation, and SIRT1.”

    Human trial50000 IU vitamin D weekly + 250 mg magnesium daily8 weeksfemalesn = 108

    Randomized study of the effects of vitamin D and/or magnesium supplementation on mood, serum levels of BDNF, inflammation, and SIRT1 in obese women with mild to moderate depressive symptoms

    Nutritional neuroscience

More on Inflammation

Latest